?
Silicone Scar Dressings are formulated from silicone-based materials and are available as gels, sheets, tapes, and creams. They are principally used in plastic surgery, dermatology, burn care, and general wound management to treat scars resulting from injuries, burns, surgeries, or other traumatic events.
The global silicone scar dressing market was $318.9 million in 2023 and will reach $495.6 million by 2030. The market's CAGR is 6.50% during the projection period.
The main reasons for this are the growing incidence of chronic wounds, for example, venous ulcers, diabetic ulcers, and pressure injuries, largely among the aging population of the world, the growing emphasis on cosmetic outcomes, and the mounting prevalence of procedures that cause scars.
With the evolution of the healthcare system at a global level, it is becoming a patient-centric care model, and the requirement for silicone scar dressing will increase, reflecting their important role in modern wound care strategies.
• North America
A recent development happened in September 2021 when Sonoma Pharmaceuticals, Inc. introduced 3 of its state-of-the-art products to the consumer market. These products, like Regenacyn Advanced Scar Gel and Ocucyn Eyelid & Eyelash Cleanser, would be offered to people without a prescription, making them readily available to consumers.
Another development struck the market in October 2023 when DuPont introduced a new gentle skin adhesive designed precisely for wound care dressings.
Several key players are present, each contributing to the industry's growth through innovation, product launches, business expansion, and an emphasis on expanding product portfolios.
Prominent Market Players
• Mölnlycke
• Smith & Nephew
• Advancis Medical
• Avocet Polymer Technologies
• B. Braun
• Bayer AG
• Espere Healthcare Ltd.
• Bio Med Sciences
• BMG Pharma spA
• CCA Industries, Inc.
As Swati Sood, Principal Analyst—BIS Research, states, "the growing number of surgical procedures, including C-sections, cosmetic surgeries, and trauma surgeries, will bring about increased demand for scar management solutions. Thus, silicone dressings will be favored as an option because of their user-friendliness and proven efficiency.
The competitive nature of the market and the existence of industry stalwarts, accompanied by ongoing R&D activities, contribute to product improvement and pricing strategies.
Approvals and standards for silicone scar dressing products also play an important role in shaping the market. Additionally, the growing emphasis on cost-effective healthcare solutions and the incorporation of cutting-edge technologies, for example, AI in wound care management, will influence the market in the future."
